Derek A Beauchamp

Title: The Innovations of Derek A Beauchamp

Introduction

Derek A Beauchamp is a notable inventor based in Schwenksville, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target metabolic disorders. With a total of three patents to his name, Beauchamp's work is recognized for its potential impact on health and medicine.

Latest Patents

One of Beauchamp's latest patents is a process for the preparation of compounds useful as inhibitors of SGLT-2. This invention focuses on a novel method for creating compounds that inhibit the sodium-dependent glucose transporter, which is crucial in the intestine and kidney. Another significant patent is for a crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)(3-(4-(thiazole-2-carbonyl)piperazin-1-yl)azetidin-1-yl)methanone. This invention includes methods for making the salt, pharmaceutical compositions containing it, and its use in treating pain and metabolic disorders such as obesity, hyperphagia, and diabetes.

Career Highlights

Derek A Beauchamp is currently employed at Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments for complex health issues.

Collaborations

Beauchamp has collaborated with notable colleagues, including Kenneth M Wells and Mark R Player. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Derek A Beauchamp's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work not only addresses critical health challenges but also showcases the importance of collaboration in scientific advancements.